| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenal Hyperplasia, Congenital | 16 | 2016 | 23 | 2.060 |
Why?
|
| Mutation | 19 | 2021 | 1213 | 1.100 |
Why?
|
| Steroid 21-Hydroxylase | 10 | 2016 | 13 | 1.070 |
Why?
|
| Bivalvia | 1 | 2020 | 10 | 0.770 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 40 | 0.770 |
Why?
|
| Endangered Species | 1 | 2020 | 9 | 0.770 |
Why?
|
| Renin | 5 | 2006 | 96 | 0.730 |
Why?
|
| Biological Evolution | 1 | 2020 | 86 | 0.720 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 4 | 2017 | 5 | 0.610 |
Why?
|
| Prenatal Diagnosis | 6 | 2005 | 73 | 0.590 |
Why?
|
| Mineralocorticoid Excess Syndrome, Apparent | 4 | 2017 | 4 | 0.570 |
Why?
|
| DNA Methylation | 3 | 2023 | 192 | 0.540 |
Why?
|
| Mineralocorticoids | 4 | 2001 | 9 | 0.450 |
Why?
|
| Hydroxysteroid Dehydrogenases | 3 | 2001 | 6 | 0.430 |
Why?
|
| Pedigree | 11 | 2016 | 159 | 0.420 |
Why?
|
| Phenotype | 7 | 2019 | 946 | 0.410 |
Why?
|
| Hypertension | 6 | 2005 | 1531 | 0.400 |
Why?
|
| Breast Neoplasms | 7 | 2019 | 1533 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2014 | 54 | 0.380 |
Why?
|
| Steroid 11-beta-Hydroxylase | 4 | 2005 | 4 | 0.370 |
Why?
|
| Nerve Sheath Neoplasms | 2 | 2021 | 33 | 0.360 |
Why?
|
| Genotype | 7 | 2017 | 785 | 0.350 |
Why?
|
| Dexamethasone | 6 | 2005 | 150 | 0.340 |
Why?
|
| Glucocorticoids | 5 | 2005 | 222 | 0.340 |
Why?
|
| Transcriptome | 3 | 2023 | 164 | 0.340 |
Why?
|
| Virilism | 4 | 2011 | 5 | 0.320 |
Why?
|
| Scleroderma, Systemic | 2 | 2023 | 446 | 0.310 |
Why?
|
| Fetal Diseases | 3 | 2005 | 64 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 756 | 0.300 |
Why?
|
| DNA Mutational Analysis | 8 | 2016 | 159 | 0.290 |
Why?
|
| Consanguinity | 5 | 2005 | 12 | 0.250 |
Why?
|
| Humans | 41 | 2023 | 68525 | 0.220 |
Why?
|
| Female | 31 | 2023 | 38015 | 0.220 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 163 | 0.210 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 1849 | 0.210 |
Why?
|
| Homozygote | 5 | 2004 | 119 | 0.210 |
Why?
|
| Gene Expression | 1 | 2004 | 770 | 0.200 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2021 | 37 | 0.200 |
Why?
|
| Genome, Human | 1 | 2021 | 62 | 0.200 |
Why?
|
| Norway | 1 | 2020 | 18 | 0.190 |
Why?
|
| Mutation, Missense | 2 | 2017 | 112 | 0.190 |
Why?
|
| Fresh Water | 1 | 2020 | 43 | 0.190 |
Why?
|
| Rivers | 1 | 2020 | 43 | 0.190 |
Why?
|
| Diencephalon | 1 | 2019 | 4 | 0.190 |
Why?
|
| Fundulidae | 1 | 2019 | 4 | 0.190 |
Why?
|
| DNA Fragmentation | 1 | 2019 | 85 | 0.180 |
Why?
|
| Mesencephalon | 1 | 2019 | 41 | 0.180 |
Why?
|
| Phenylenediamines | 1 | 2019 | 16 | 0.180 |
Why?
|
| Sus scrofa | 1 | 2019 | 74 | 0.180 |
Why?
|
| Spermatozoa | 1 | 2019 | 75 | 0.180 |
Why?
|
| Receptor, ErbB-4 | 1 | 2019 | 13 | 0.180 |
Why?
|
| Genetic Testing | 1 | 2020 | 159 | 0.170 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 60 | 0.170 |
Why?
|
| Child | 12 | 2017 | 6400 | 0.170 |
Why?
|
| Receptor, ErbB-2 | 1 | 2019 | 128 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1998 | 19 | 0.170 |
Why?
|
| Child, Preschool | 10 | 2017 | 3185 | 0.170 |
Why?
|
| Chorionic Villi Sampling | 3 | 2005 | 6 | 0.160 |
Why?
|
| Pyrimidines | 1 | 2019 | 178 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2016 | 161 | 0.160 |
Why?
|
| Infant | 7 | 2017 | 2891 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 627 | 0.150 |
Why?
|
| Protein Multimerization | 1 | 2017 | 71 | 0.150 |
Why?
|
| Gene Frequency | 4 | 2013 | 207 | 0.140 |
Why?
|
| Oncogene Proteins | 1 | 2016 | 35 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 34 | 0.140 |
Why?
|
| Systems Analysis | 1 | 2016 | 33 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2016 | 111 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2016 | 93 | 0.140 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1173 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 33 | 0.140 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 53 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2021 | 902 | 0.140 |
Why?
|
| Prostate | 1 | 2016 | 116 | 0.130 |
Why?
|
| Pregnancy | 6 | 2005 | 2331 | 0.130 |
Why?
|
| Animals | 7 | 2020 | 20877 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 65 | 0.130 |
Why?
|
| Male | 19 | 2019 | 37281 | 0.130 |
Why?
|
| Breast | 1 | 2016 | 137 | 0.130 |
Why?
|
| EGF Family of Proteins | 1 | 2014 | 17 | 0.130 |
Why?
|
| Machine Learning | 1 | 2016 | 170 | 0.130 |
Why?
|
| Estrogens | 1 | 2016 | 173 | 0.130 |
Why?
|
| Histone Acetyltransferases | 1 | 2014 | 13 | 0.130 |
Why?
|
| Infant, Newborn | 5 | 2016 | 2453 | 0.120 |
Why?
|
| Algorithms | 3 | 2016 | 1194 | 0.120 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 57 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 271 | 0.120 |
Why?
|
| Base Sequence | 3 | 2016 | 1015 | 0.120 |
Why?
|
| Oncogenes | 1 | 2014 | 71 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 107 | 0.120 |
Why?
|
| Amniocentesis | 2 | 2005 | 12 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 106 | 0.120 |
Why?
|
| Aldosterone | 2 | 2006 | 51 | 0.120 |
Why?
|
| Software | 1 | 2016 | 418 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2014 | 239 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1070 | 0.110 |
Why?
|
| Exons | 3 | 2016 | 122 | 0.110 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 103 | 0.100 |
Why?
|
| Clitoris | 1 | 2011 | 2 | 0.100 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2011 | 2 | 0.100 |
Why?
|
| Androgens | 2 | 2001 | 40 | 0.090 |
Why?
|
| CpG Islands | 2 | 2021 | 51 | 0.090 |
Why?
|
| Cortisone | 2 | 2001 | 3 | 0.090 |
Why?
|
| Hydrocortisone | 3 | 2001 | 291 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 778 | 0.090 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1999 | 57 | 0.090 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 2 | 1999 | 5 | 0.090 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2006 | 6 | 0.090 |
Why?
|
| Adolescent | 8 | 2017 | 8903 | 0.090 |
Why?
|
| Gene Deletion | 2 | 2013 | 235 | 0.080 |
Why?
|
| Point Mutation | 2 | 2016 | 97 | 0.070 |
Why?
|
| Adrenal Gland Diseases | 2 | 2003 | 6 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2019 | 1199 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2019 | 222 | 0.070 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2004 | 106 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 498 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 235 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2005 | 31 | 0.070 |
Why?
|
| Genetic Carrier Screening | 1 | 2005 | 25 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2016 | 2356 | 0.060 |
Why?
|
| Codon | 1 | 2004 | 21 | 0.060 |
Why?
|
| Sodium | 1 | 2005 | 161 | 0.060 |
Why?
|
| RNA Interference | 2 | 2016 | 266 | 0.060 |
Why?
|
| Cricetulus | 1 | 2004 | 98 | 0.060 |
Why?
|
| CHO Cells | 1 | 2004 | 161 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2004 | 60 | 0.060 |
Why?
|
| Cricetinae | 1 | 2004 | 262 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2017 | 705 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 300 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1032 | 0.060 |
Why?
|
| Monocytes | 1 | 2023 | 210 | 0.050 |
Why?
|
| Croatia | 2 | 2016 | 8 | 0.050 |
Why?
|
| Siblings | 2 | 2016 | 34 | 0.050 |
Why?
|
| Heterozygote | 1 | 2001 | 174 | 0.050 |
Why?
|
| HLA Antigens | 2 | 2016 | 82 | 0.050 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 18 | 0.050 |
Why?
|
| Karyotyping | 1 | 2021 | 74 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2021 | 47 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2001 | 117 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 31 | 0.050 |
Why?
|
| Syndrome | 1 | 2001 | 255 | 0.050 |
Why?
|
| Alleles | 2 | 2016 | 386 | 0.050 |
Why?
|
| Christianity | 1 | 1999 | 16 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1999 | 20 | 0.050 |
Why?
|
| Aneuploidy | 1 | 1999 | 21 | 0.050 |
Why?
|
| Endocrinology | 1 | 1999 | 16 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 19 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2019 | 25 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1999 | 62 | 0.040 |
Why?
|
| Phospholipase C gamma | 1 | 2019 | 13 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 1999 | 43 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2019 | 18 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 1999 | 56 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 190 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 86 | 0.040 |
Why?
|
| Phylogeny | 1 | 2019 | 196 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 614 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 226 | 0.040 |
Why?
|
| ras Proteins | 1 | 2019 | 102 | 0.040 |
Why?
|
| Gestational Age | 1 | 1999 | 389 | 0.040 |
Why?
|
| DNA Primers | 1 | 1998 | 302 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2017 | 30 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 328 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 1999 | 281 | 0.040 |
Why?
|
| New York | 2 | 2013 | 223 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 1172 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 785 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 332 | 0.040 |
Why?
|
| Oman | 1 | 2016 | 1 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 331 | 0.040 |
Why?
|
| DNA, Intergenic | 1 | 2016 | 8 | 0.040 |
Why?
|
| RNA Editing | 1 | 2016 | 5 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2016 | 36 | 0.040 |
Why?
|
| Introns | 1 | 2016 | 68 | 0.040 |
Why?
|
| Pediatrics | 1 | 1999 | 341 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 56 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 68 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2016 | 87 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 100 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 260 | 0.030 |
Why?
|
| Chromatin | 1 | 2016 | 76 | 0.030 |
Why?
|
| Cholecalciferol | 1 | 2016 | 143 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 329 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 170 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 98 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 326 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3256 | 0.030 |
Why?
|
| Amphiregulin | 1 | 2014 | 19 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2014 | 30 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 166 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 45 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2014 | 79 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 546 | 0.030 |
Why?
|
| Family | 1 | 2016 | 293 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 1082 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 114 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 218 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 196 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 84 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2016 | 331 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 207 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 682 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 475 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 852 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 508 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 1752 | 0.030 |
Why?
|
| Adrenal Cortex | 2 | 2003 | 8 | 0.030 |
Why?
|
| Cell Movement | 1 | 2014 | 630 | 0.030 |
Why?
|
| Protein Binding | 1 | 2014 | 1027 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2011 | 89 | 0.020 |
Why?
|
| Adrenal Glands | 2 | 2001 | 46 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2001 | 150 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 2688 | 0.020 |
Why?
|
| Turkey | 1 | 2009 | 7 | 0.020 |
Why?
|
| Adult | 5 | 2006 | 21375 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 2093 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 3702 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 2790 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1139 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 8472 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 319 | 0.020 |
Why?
|
| Microchemistry | 1 | 2005 | 19 | 0.020 |
Why?
|
| Haplotypes | 1 | 2005 | 174 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2005 | 43 | 0.020 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2004 | 1 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 2003 | 5 | 0.020 |
Why?
|
| Fertility | 1 | 2004 | 60 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2004 | 38 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 492 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2003 | 186 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 710 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 597 | 0.010 |
Why?
|
| Biomarkers | 1 | 2006 | 1593 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 14842 | 0.010 |
Why?
|
| Gonadal Disorders | 1 | 1999 | 2 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1999 | 18 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 2264 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1999 | 21 | 0.010 |
Why?
|
| Indians, North American | 1 | 1999 | 64 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1999 | 32 | 0.010 |
Why?
|
| Thyroid Diseases | 1 | 1999 | 33 | 0.010 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1999 | 79 | 0.010 |
Why?
|
| Radiography | 1 | 2001 | 572 | 0.010 |
Why?
|
| Ovary | 1 | 1999 | 99 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 1999 | 91 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 1851 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1999 | 223 | 0.010 |
Why?
|
| Steroids | 1 | 1999 | 84 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 21119 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1999 | 753 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 1582 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 7264 | 0.010 |
Why?
|